SEC Form 4 · accession 0001104659-15-044672
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Elliott Boulding
Officer — Exec VP and CLO
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2015 | M | 12,083 | $10.85 | A | 23,176 | D | |
| Common Stock | Jun 8, 2015 | M | 50,000 | $10.85 | A | 73,176 | D | |
| Common StockF2 | Jun 8, 2015 | S | 10,776 | $53.87 | D | 62,400 | D | |
| Common StockF3 | Jun 8, 2015 | S | 18,324 | $54.70 | D | 44,076 | D | |
| Common StockF4 | Jun 8, 2015 | S | 24,609 | $55.62 | D | 19,467 | D | |
| Common StockF5 | Jun 8, 2015 | S | 3,140 | $56.42 | D | 16,327 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $10.85 | Jun 8, 2015 | M | 12,083 | D | — | May 15, 2023 | Common Stock | 12,083 | 7,917 | D |
| Stock Option (Right to Buy)F7 | $10.85 | Jun 8, 2015 | M | 50,000 | D | — | May 15, 2023 | Common Stock | 50,000 | 50,000 | D |
| Stock Option (Right to Buy)F8 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 80,000 | 80,000 | D |
| Stock Option (Right to Buy)F9 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 85,600 | 85,600 | D |
| Stock Option (Right to Buy)F10 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 191 | 191 | D |
| Stock Option (Right to Buy)F11 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 233 | 233 | D |
| Stock Option (Right to Buy)F11 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 200 | 200 | D |
| Stock Option (Right to Buy)F11 | $451.20 | holding | — | — | — | — | May 15, 2019 | Common Stock | 233 | 233 | D |
| Stock Option (Right to Buy)F11 | $735.60 | holding | — | — | — | — | Apr 1, 2018 | Common Stock | 195 | 195 | D |
| Stock Option (Right to Buy)F11 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 166 | 166 | D |
| Stock Option (Right to Buy)F11 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 216 | 216 | D |
| Stock Option (Right to Buy)F11 | $392.40 | holding | — | — | — | — | Mar 1, 2016 | Common Stock | 101 | 101 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of diversification.
- F10This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013.
- F11Currently exercisable.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.26 to $54.25 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.26 to $55.19 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.26 to $56.21 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.29 to $56.63 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
- F7This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- F8This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F9This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.